Related Experiment Video
Updated: Jul 20, 2026

In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
Motor neuron disease associated with copper deficiency.
1Department of Neurology, Washington University School of Medicine, Campus Box 8111, 660 South Euclid Avenue, St. Louis, Missouri 63110, USA.
Copper deficiency can cause lower motor neuron disease, not just spastic ataxia. Early copper replacement may stabilize or improve muscle weakness in affected individuals.
Area of Science:
- Neurology
- Nutritional Neuroscience
Background:
- Copper deficiency is a rare cause of myeloneuropathy.
- It typically presents as spastic ataxia, hyperreflexia, and distal sensory loss, mimicking subacute combined degeneration.
- However, the clinical spectrum may be broader.
Observation:
- Three patients with copper deficiency were observed.
- Two patients were initially diagnosed with amyotrophic lateral sclerosis.
- Patients exhibited progressive weakness and denervation, suggesting lower motor neuron disease.
Findings:
- Copper replacement therapy led to stabilization or mild improvement in muscle weakness.
- The study expands the clinical spectrum of copper deficiency.
Implications:
- Human copper deficiency should be considered in cases of lower motor neuron disease.
- This expands the differential diagnosis beyond spastic ataxia syndromes.
More Related Videos
11:04Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides
Published on: September 7, 2019
06:51Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
Related Concept Videos
Myasthenia Gravis ll: Pathophysiology
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Multiple Sclerosis l: Introduction
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...